Neogen Corporation (NASDAQ:NEOG – Get Free Report) has been given an average rating of “Hold” by the six brokerages that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $10.6667.
A number of brokerages recently issued reports on NEOG. Wall Street Zen raised Neogen from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Weiss Ratings lowered Neogen from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday.
Check Out Our Latest Analysis on NEOG
Neogen Price Performance
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in NEOG. JPMorgan Chase & Co. raised its holdings in shares of Neogen by 19.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,680,212 shares of the company’s stock valued at $9,594,000 after acquiring an additional 278,886 shares in the last quarter. SG Americas Securities LLC grew its holdings in shares of Neogen by 929.6% during the fourth quarter. SG Americas Securities LLC now owns 1,617,597 shares of the company’s stock worth $11,307,000 after purchasing an additional 1,460,488 shares in the last quarter. Roubaix Capital LLC purchased a new position in shares of Neogen during the first quarter worth about $4,630,000. Bessemer Group Inc. increased its position in shares of Neogen by 160,972.5% in the first quarter. Bessemer Group Inc. now owns 1,565,625 shares of the company’s stock worth $14,545,000 after purchasing an additional 1,564,653 shares during the last quarter. Finally, Round Rock Advisors LLC increased its position in shares of Neogen by 520.8% in the fourth quarter. Round Rock Advisors LLC now owns 156,967 shares of the company’s stock worth $1,097,000 after purchasing an additional 131,684 shares during the last quarter. 96.73% of the stock is currently owned by hedge funds and other institutional investors.
About Neogen
Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.
In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.
Featured Stories
- Five stocks we like better than Neogen
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.
